Author:
Fatmawati Farah,Wijaksono Whendy
Abstract
Tumor angiogenesis, a process in which blood vessels penetrate and grow in a tumor environment, is needed for oxygen and nutrient supply and plays an important role in the survival of solid neoplasms. Angiogenesis does not only have a role in tumor development and metastasis, but also acts as marker of cancer itself (hallmark of cancer). Several mechanisms of angiogenesis include vasculogenesis, sprouting angiogenesis, intussusception microgrowth, and vasculogenic mimicry. Knowing these different mechanisms will be helpful in choosing the best agents or drugs for cancer therapy. The first anti-angiogenic drug used was bevacizumab, a monoclonal antibody, directed against VEGF. Bevacizumab has significant clinical benefits in patients with advanced NSCLC.
Reference21 articles.
1. Cell Trafficking of Endothelial Progenitor Cells in Tumor Progression;Puente P;Clinical Cancer Research,2013
2. Darland C and D'Amore PA. Endothelial Cells and Pericytes in Tumor Vasculature. In: Voest EE and D'Amore PA, (Eds.). Tumor Angiogenesis and Microcirculation. Switzerland: Marcell Dekker, Inc., 2001, P. 1-2.
3. Folkman J. Tumor Angiogenesis: From Bench to Bedside. In: Marmé D and Fusenig N, (Eds.). Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy. Berlin, Heidelberg: Springer Berlin Heidelberg, 2008, P. 3-28.
4. Eichmann A, Bouvrée K and Pardanaud L. Vasculogenesis and Angiogenesis In Development. In: Marmé D and Fusenig N, (Eds.). Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy. Berlin, Heidelberg: Springer Berlin Heidelberg, 2008, P. 31-45.
5. Kedokteran PNP. Kanker Paru. In: Nasional KPK, (Ed.). Jakarta: Komite Penanggulangan Kanker Nasional, 2017.